Transketolase (TKT) Peptide
TKT
Reactivity: Mammalian
Host: Synthetic
BP, IHC, WB
Catalog No. ABIN938139
Quick Overview for Transketolase (TKT) Peptide (ABIN938139)
Target
TKT
(Transketolase (TKT))
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
-
-
Peptide Type
- Synthetic
-
Sequence
- ESYHKPDQQK LQALKDTANR LRISSIQATT AAGSGHPTSC CSAAEIMAVL
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of TKT antibody,
Alternative Names: TKT control peptide, TKT antibody Blocking Peptide, Anti-TKT Blocking Peptide, Transketolase Blocking Peptide, Wernicke-Korsakoff Syndrome Blocking Peptide, FLJ34765 Blocking Peptide, TKT1 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- TKT (Transketolase (TKT))
-
Background
- TKT belongs to the transketolase family. TKT has been implicated in the latent genetic disease Wernicke-Korsakoff syndrome (WKS), which causes specific brain damage.
-
Molecular Weight
- 68 kDa
Target
-
You are here:
